Geode Capital Management
PTCT icon

Geode Capital Management’s PTC Therapeutics PTCT Stock Holding History

Geode Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$180M Sell
2,207,376
-2,578
-0.1% -$186K 0.01% 862
2026
Q1 		$151M Buy
2,209,954
+193,892
+10% +$13.7M 0.01% 853
2025
Q4 		$153M Buy
2,016,062
+65,184
+3% +$4.74M 0.01% 834
2025
Q3 		$120M Buy
1,950,878
+16,285
+0.8% +$848K 0.01% 960
2025
Q2 		$94.5M Buy
1,934,593
+60,707
+3% +$2.88M 0.01% 1063
2025
Q1 		$95.5M Buy
1,873,886
+76,870
+4% +$3.84M 0.01% 996
2024
Q4 		$81.1M Sell
1,797,016
-1,650
-0.1% -$70.6K 0.01% 1126
2024
Q3 		$66.7M Buy
1,798,666
+10,886
+0.6% +$364K 0.01% 1252
2024
Q2 		$54.7M Buy
1,787,780
+124,712
+7% +$4.04M ﹤0.01% 1295
2024
Q1 		$48.4M Buy
1,663,068
+51,843
+3% +$1.45M ﹤0.01% 1378
2023
Q4 		$44.4M Buy
1,611,225
+89,396
+6% +$2.04M ﹤0.01% 1417
2023
Q3 		$34.1M Buy
1,521,829
+62,289
+4% +$2.32M ﹤0.01% 1490
2023
Q2 		$59.4M Buy
1,459,540
+74,130
+5% +$3.63M 0.01% 1123
2023
Q1 		$67.1M Buy
1,385,410
+58,786
+4% +$2.69M 0.01% 987
2022
Q4 		$50.6M Buy
1,326,624
+47,426
+4% +$1.97M 0.01% 1137
2022
Q3 		$64.2M Sell
1,279,198
-54,321
-4% -$2.66M 0.01% 918
2022
Q2 		$53.4M Buy
1,333,519
+42,380
+3% +$1.49M 0.01% 1067
2022
Q1 		$48.2M Buy
1,291,139
+19,009
+1% +$732K 0.01% 1277
2021
Q4 		$50.7M Sell
1,272,130
-6,496
-0.5% -$249K 0.01% 1305
2021
Q3 		$47.6M Buy
1,278,626
+11,287
+0.9% +$464K 0.01% 1321
2021
Q2 		$53.6M Buy
1,267,339
+118,239
+10% +$5.07M 0.01% 1248
2021
Q1 		$54.4M Buy
1,149,100
+104,952
+10% +$6.23M 0.01% 1162
2020
Q4 		$63.7M Buy
1,044,148
+64,473
+7% +$3.8M 0.01% 948
2020
Q3 		$45.8M Buy
979,675
+18,444
+2% +$908K 0.01% 968
2020
Q2 		$48.8M Buy
961,231
+33,785
+4% +$1.66M 0.01% 906
2020
Q1 		$41.4M Buy
927,446
+67,097
+8% +$3.38M 0.01% 861
2019
Q4 		$41.3M Buy
860,349
+73,080
+9% +$3.11M 0.01% 1062
2019
Q3 		$26.6M Buy
787,269
+52,852
+7% +$2.3M 0.01% 1287
2019
Q2 		$33M Buy
734,417
+53,069
+8% +$2.1M 0.01% 1136
2019
Q1 		$25.6M Buy
681,348
+117,942
+21% +$3.96M 0.01% 1252
2018
Q4 		$19.3M Buy
563,406
+37,593
+7% +$1.35M 0.01% 1305
2018
Q3 		$24.7M Buy
525,813
+79,294
+18% +$3.28M 0.01% 1251
2018
Q2 		$15.1M Buy
446,519
+81,197
+22% +$2.53M ﹤0.01% 1564
2018
Q1 		$9.88M Buy
365,322
+50,210
+16% +$1.27M ﹤0.01% 1771
2017
Q4 		$5.26M Sell
315,112
-47,893
-13% -$811K ﹤0.01% 2182
2017
Q3 		$7.26M Buy
363,005
+71,590
+25% +$1.4M ﹤0.01% 1968
2017
Q2 		$5.34M Buy
291,415
+21,151
+8% +$285K ﹤0.01% 2105
2017
Q1 		$2.66M Buy
270,264
+10,958
+4% +$133K ﹤0.01% 2494
2016
Q4 		$2.83M Buy
259,306
+30,111
+13% +$316K ﹤0.01% 2425
2016
Q3 		$3.21M Buy
229,195
+3,442
+2% +$28K ﹤0.01% 2254
2016
Q2 		$1.58M Buy
225,753
+1,700
+0.8% +$12.5K ﹤0.01% 2640
2016
Q1 		$1.44M Buy
224,053
+5,167
+2% +$89.7K ﹤0.01% 2670
2015
Q4 		$7.09M Buy
218,886
+4,743
+2% +$140K ﹤0.01% 1616
2015
Q3 		$5.72M Buy
214,143
+55,661
+35% +$2.38M ﹤0.01% 1757
2015
Q2 		$7.63M Buy
158,482
+13,379
+9% +$781K ﹤0.01% 1609
2015
Q1 		$8.83M Sell
145,103
-985
-0.7% -$60.1K 0.01% 1477
2014
Q4 		$7.56M Buy
146,088
+16,134
+12% +$710K ﹤0.01% 1554
2014
Q3 		$5.72M Buy
129,954
+2,122
+2% +$66.4K ﹤0.01% 1679
2014
Q2 		$3.34M Buy
127,832
+27,938
+28% +$598K ﹤0.01% 2051
2014
Q1 		$2.61M Buy
99,894
+50,799
+103% +$1.37M ﹤0.01% 2180
2013
Q4 		$833K Buy
49,095
+693
+1% +$12.2K ﹤0.01% 2829
2013
Q3 		$1.04M Buy
+48,402
New +$841K ﹤0.01% 2567

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Geode Capital Management's PTCT Position: Q2 2026 in Review

Geode Capital Management reduced its PTC Therapeutics (PTCT) stake by 0.12% in Q2 2026, selling an estimated $186K and leaving 2,207,376 shares worth $180M. The position accounts for 0.01% of the portfolio, ranked #862.

Geode Capital Management first reported a position in PTCT in Q3 2013 and has held it in 52 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Geode Capital Management held 2,207,376 shares of PTC Therapeutics worth $180M as of Q2 2026.
  • Geode Capital Management sold 2,578 PTC Therapeutics shares in Q2 2026, an estimated $186K.
  • PTC Therapeutics made up 0.01% of Geode Capital Management's portfolio in Q2 2026, its #862 holding.
  • Geode Capital Management first reported a position in PTC Therapeutics in Q3 2013 and has held it in 52 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.